Pulse Biosciences (PLSE) Asset Utilization Ratio (2022 - 2026)

Pulse Biosciences (PLSE) posted Asset Utilization Ratio of 0.01 for Q2 2026, up 116.75% on a QoQ basis from 0.0 in Q4 2025.

Analysis

Pulse Biosciences (PLSE) Asset Utilization Ratio (2022 - 2026) Analysis & Trends

Pulse Biosciences has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.01 in Q2 2026.

On a quarterly basis, Asset Utilization Ratio changed N/A year-over-year to 0.01 in Q2 2026; TTM through Jun 2026 was 0.01, a N/A change from a year earlier, with the FY2025 full-year figure at 0.0, changed N/A from the prior year.
Asset Utilization Ratio was 0.01 for Q2 2026 at Pulse Biosciences, up from 0.0 in the prior quarter.
The five-year high for Asset Utilization Ratio was 0.05 in Q2 2022, with the low at 0.0 in Q3 2023.
Average Asset Utilization Ratio over 4 years is 0.01, with a median of 0.0 recorded in 2023.
The largest YoY upside for Asset Utilization Ratio was 100.23% in 2023 against a maximum downside of 100.52% in 2023.
Over 4 years, Asset Utilization Ratio stood at 0.01 in 2022, then sank by 101.44% to 0.0 in 2023, then soared by 2791.41% to 0.0 in 2025, then surged by 116.75% to 0.01 in 2026.
The last three Asset Utilization Ratio figures came in at 0.01 (Q2 2026), 0.0 (Q4 2025), and 0.0 (Q3 2025), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Abbott Laboratories	179.79 Bn	174.18 Bn	7.27 Bn	0.42
2	Intuitive Surgical	127.69 Bn	122.47 Bn	1.96 Bn	0.54
3	Medtronic	117.23 Bn	108.41 Bn	6.34 Bn	0.40
4	Stryker	103.55 Bn	100.07 Bn	4.50 Bn	0.55
5	Boston Scientific	63.24 Bn	62.70 Bn	3.85 Bn	0.47
6	Edwards Lifesciences	49.97 Bn	45.72 Bn	1.35 Bn	0.48
7	Alcon	32.83 Bn	31.37 Bn	1.68 Bn	0.34
8	Dexcom	32.30 Bn	30.35 Bn	830.00 Mn	0.76
9	Steris	20.73 Bn	20.25 Bn	684.20 Mn	0.56
10	Pulse Biosciences	3.76 Bn	3.76 Bn	161,000.00	0.01

Historic Data

Download Data